Heart Rhythm
Volume 7, Issue 7 , Pages 876-882, July 2010

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis

  • Pasquale Santangeli, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Pasquale Santangeli, Cardiology Department, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy
  • ,
  • Gemma Pelargonio, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Antonio Dello Russo, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Michela Casella, MD, PhD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Caterina Bisceglia, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Stefano Bartoletti, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Pietro Santarelli, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
  • ,
  • Luigi Di Biase, MD

      Affiliations

    • Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    • Department of Cardiology, University of Foggia, Foggia, Italy
    • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas
  • ,
  • Andrea Natale, MD, FHRS

      Affiliations

    • Department of Biomedical Engineering, University of Texas, Austin, Texas
    • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas

Received 28 December 2009; accepted 31 March 2010. published online 08 April 2010.

Background

Women are underrepresented in primary prevention implantable cardioverter-defibrillator (ICD) trials, and data on the benefit of ICD therapy in this subgroup are controversial.

Objective

The purpose of this study was to better evaluate the benefit of prophylactic ICD in women by performing a meta-analysis of primary prevention ICD trials that assessed gender differences on the end-points of total mortality, appropriate ICD intervention, and survival benefit of ICD compared with placebo.

Methods

PubMed, CENTRAL, and other databases were searched in October 2009. Studies were included only if they examined gender differences in the specified end-points, providing the hazard ratio (HR) obtained in multiple Cox regression analyses, and adjusted for all confounding variables.

Results

We retrieved five studies (MADIT-II, MUSTT, SCD-HeFT, DEFINITE, COMPANION) that enrolled 7,229 patients (22% women) with dilated cardiomyopathy (74% ischemic). Compared to men, women had no significant difference in overall mortality (HR 0.96, 95% confidence interval [CI] 0.67–1.39, P = .84) but experienced significantly less appropriate ICD interventions (HR 0.63, 95% CI 0.49–0.82, P ≤.001). The benefit of ICD on mortality was significantly higher in men (HR 0.67, 95% CI 0.58–0.78, P <.001) but did not reach statistical significance in women (HR 0.78, 95% CI 0.57–1.05, P = .1).

Conclusion

Women enrolled in primary prevention ICD trials have the same mortality compared to men while experiencing significantly less appropriate ICD interventions, thus suggesting a smaller impact of sudden cardiac death on overall mortality in women with dilated cardiomyopathy. These findings may explain the smaller ICD survival benefit among women.

Keywords: Dilated cardiomyopathy, Gender differences, Implantable cardioverter-defibrillator, Sudden cardiac death

Abbreviations: CI, confidence interval, DCM, dilated cardiomyopathy, HR, hazard ratio, ICD, implantable cardioverter-defibrillator, LVEF, left ventricular ejection fraction, SCD, Sudden cardiac death

 

 Dr. Natale has received compensation for belonging to the speakers' bureau for St. Jude Medical, Boston Scientific, Medtronic, and Biosense Webster and has received a research grant from St. Jude Medical.

PII: S1547-5271(10)00336-X

doi:10.1016/j.hrthm.2010.03.042

Heart Rhythm
Volume 7, Issue 7 , Pages 876-882, July 2010